PMID- 31243572 OWN - NLM STAT- MEDLINE DCOM- 20190827 LR - 20190827 IS - 1432-0584 (Electronic) IS - 0939-5555 (Linking) VI - 98 IP - 9 DP - 2019 Sep TI - miR-144 regulates oxidative stress tolerance of thalassemic erythroid cell via targeting NRF2. PG - 2045-2052 LID - 10.1007/s00277-019-03737-4 [doi] AB - Thalassemia has a high prevalence in Thailand. Oxidative damage to erythroid cells is known to be one of the major etiologies in thalassemia pathophysiology. Oxidative stress status of thalassemia is potentiated by the heme, nonheme iron, and free iron resulting from imbalanced globin synthesis. In addition, levels of antioxidant proteins are reduced in alpha-thalassemia and beta-thalassemia erythrocytes. However, the primary molecular mechanism for this phenotype remains unknown. Our study showed a high expression of miR-144 in beta- and alpha-thalassemia. An increased miR-144 expression leads to decreased expression of nuclear factor erythroid 2-related factor 2 (NRF2) target, especially in alpha-thalassemia. In alpha-thalassemia, miR-144 and NRF2 target are associated with glutathione level and anemia severity. To study the effect of miR-144 expression, the gain-loss of miR-144 expression was performed by miR inhibitor and mimic transfection in the erythroblastic cell line. This study reveals that miR-144 expression was upregulated, whereas NRF2 expression and glutathione levels were decreased in comparison with the untreated condition after miR mimic transfection, while the reduction of miR-144 expression contributed to the increased NRF2 expression and glutathione level compared with the untreated condition after miR inhibitor transfection. Moreover, miR-144 overexpression leads to significantly increased sensitivity to oxidative stress at indicated concentrations of hydrogen peroxide (H(2)O(2)) and rescued by miR-144 inhibitor. Taken together, our findings suggest that dysregulation of miR-144 may play a role in the reduced ability of erythrocyte to deal with oxidative stress and increased RBC hemolysis susceptibility especially in thalassemia. FAU - Srinoun, Kanitta AU - Srinoun K AUID- ORCID: 0000-0003-1806-2544 AD - Faculty of Medical Technology, Prince of Songkla University, 15, Kanjanavanit Rd. Hat Yai, Songkhla, 90110, Thailand. kanitta.s@psu.ac.th. FAU - Sathirapongsasuti, Nuankanya AU - Sathirapongsasuti N AD - Section for Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 25/25, 270 Rama VI Rd., Ratchathewi, Bangkok, 10400, Thailand. FAU - Paiboonsukwong, Kittiphong AU - Paiboonsukwong K AD - Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, 25/25, Putthamonthon Sai 4 Rd. Salaya, Putthamonthon, Nakron Pratom, 73170, Thailand. FAU - Sretrirutchai, Somporn AU - Sretrirutchai S AD - Department of Pathology, Faculty of Medicine, Prince of Songkla University, 15, Kanjanavanit Rd. Hat Yai, Songkhla, 90110, Thailand. FAU - Wongchanchailert, Malai AU - Wongchanchailert M AD - Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, 15, Kanjanavanit Rd. Hat Yai, Songkhla, 90110, Thailand. FAU - Fucharoen, Suthat AU - Fucharoen S AD - Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, 25/25, Putthamonthon Sai 4 Rd. Salaya, Putthamonthon, Nakron Pratom, 73170, Thailand. LA - eng GR - TRG5780103/Thailand Research Fund (TH)/ GR - MET6201015S/the government budget of Prince of Songkla University/ PT - Journal Article DEP - 20190626 PL - Germany TA - Ann Hematol JT - Annals of hematology JID - 9107334 RN - 0 (MIRN144 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (NF-E2-Related Factor 2) RN - 0 (NFE2L2 protein, human) RN - BBX060AN9V (Hydrogen Peroxide) RN - GAN16C9B8O (Glutathione) SB - IM MH - Erythrocytes/*metabolism/pathology MH - Female MH - Glutathione/biosynthesis/genetics MH - Hemolysis MH - Humans MH - Hydrogen Peroxide/metabolism MH - K562 Cells MH - Male MH - MicroRNAs/*biosynthesis/genetics MH - NF-E2-Related Factor 2/*biosynthesis/genetics MH - *Oxidative Stress MH - *Up-Regulation MH - alpha-Thalassemia/genetics/*metabolism/pathology MH - beta-Thalassemia/genetics/*metabolism/pathology OTO - NOTNLM OT - Hemolysis OT - Oxidative stress OT - Thalassemia OT - miR-144 EDAT- 2019/06/28 06:00 MHDA- 2019/08/28 06:00 CRDT- 2019/06/28 06:00 PHST- 2018/10/07 00:00 [received] PHST- 2019/06/10 00:00 [accepted] PHST- 2019/06/28 06:00 [pubmed] PHST- 2019/08/28 06:00 [medline] PHST- 2019/06/28 06:00 [entrez] AID - 10.1007/s00277-019-03737-4 [pii] AID - 10.1007/s00277-019-03737-4 [doi] PST - ppublish SO - Ann Hematol. 2019 Sep;98(9):2045-2052. doi: 10.1007/s00277-019-03737-4. Epub 2019 Jun 26.